The American Academy of Family Physicians (AAFP) Family Medicine Experience (FMX) is the largest annual gathering of family physicians, residents, and medical students in the United States. Drawing nearly 10,000 attendees, FMX brings together clinicians from across the country to explore the latest clinical updates, earn continuing medical education (CME) credits, and connect with peers to advance the future of family medicine.
Binding Site is proud to participate in AAFP FMX 2025. We look forward to connecting with primary care professionals to discuss the importance of earlier detection for multiple myeloma and how Freelite® assays support clinical decision-making and patient care.
Visit Binding Site at booth #380 to speak with our team and learn how Freelite® assays can help support earlier detection and aid in the diagnosis of multiple myeloma in primary care. Our experts will be available throughout the event to:
Share insights into how Freelite® assays aid in patient management
A time-tested and proven solution for kappa and lambda serum free light chain (sFLC) analysis as an aid in the detection and monitoring of multiple myeloma as well as evaluating monoclonal gammopathy of undetermined significance (MGUS).
From the patient journey to clinical insights: What primary care needs to know about multiple myeloma
Join Binding Site at AAFP FMX for an educational session designed specifically for family medicine and primary care providers. Learn about the critical role you play in recognizing nonspecific symptoms, identifying populations at higher risk, and ordering the essential diagnostic tests to support earlier detection of multiple myeloma.
Date: Wednesday, October 8
Time: 8:00 a.m.
Location: Room 207CD
This program is not for CME credit and is consistent with the PhRMA Code on Interactions with Health Care Professionals.
Freelite is a registered trademark of the Binding Site Group Limited (Birmingham, UK) in certain countries.